B
국제약품
002720KOSPI64.0 / 100
Reference Date: 2026-10-23
Financial Score27.5 / 40
News Sentiment12.5 / 25
Momentum14.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 8.5% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Korea Pharmaceutical Co., Ltd. is a company engaged in the manufacture and sale of specialty and general pharmaceuticals, including Quron Eye Drops and Colensina Soft Capsules. With headquarters in Seongnam and manufacturing/R&D facilities in Ansan, the company achieved a 12.2% increase in consolidated sales to 175,496 million won in fiscal year 2025, while conducting 5 ongoing drug development projects.
Number of Employees
272people
Average Salary
68.5M KRW
Score Calculation Basis
Detailed Financial Score
PER
12.79Industry Average 15.005.0Point
In line with industry avg
PBR
0.78Industry Average 1.205.5Point
Lower than industry avg (good)
ROE
6.09Industry Average 8.002.5Point
Below industry avg
Debt Ratio
23.09Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲13.9% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲214.6% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 0.5% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (24%)
Current 3,580Won52-week high 5,23052-week low 3,045
1-month return5.0Point
1m +8.48% (rising)
Volume trend6.0Point
Volume surge
Detailed Disclosure
5 totalPositive 0Neutral 5Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-08
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-08
- Neutral주식등의대량보유상황보고서(일반)2026-10-07
- Neutral최대주주변경2026-10-06
- Neutral최대주주등소유주식변동신고서(최대주주변경시)2026-10-06